Efficacy of Nintedanib Per os as a Treatment for Epistaxis in HHT Disease.
Clinical trial NCT03954782 · COMPLETED
Trial details
- NCT number
- NCT03954782
- Sponsor
- Hospices Civils de Lyon
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-22
- Primary completion
- 2023-02-24
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.